Abstract: The flush air data sensing (FADS) system resolves air data state issues through redundant measurements of surface pressure distributions on the vehicle, with its fault-tolerant algorithm ...
Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...
Thanks to computer numerical control (CNC) fabrication technologies, the method may also be applied to design-laminated timber gridshells. Credit: ©2025 Masaaki Miki and Toby Mitchell CC-BY-ND A new ...
SAN FRANCISCO, Oct 22 (Reuters) - Google said it has developed a computer algorithm that points the way to practical applications for quantum computing and will be able to generate unique data for use ...
President Trump said Chinese leader Xi Jinping approved a deal for a group of American investors to take control of TikTok’s U.S. operations. Photo: Mandel Ngan/AFP/Getty Images The future of TikTok ...
A deal to prevent a US TikTok ban is now in place. The app’s algorithm will be copied, overseen by Oracle, and retrained using only American user data. This new, separate system addresses national ...
In his 1960 book Theory and Design in the First Machine Age, the critic and historian Reyner Banham presciently noted a growing chasm between technological change and the capacity of designers to ...
This article was originally published at The Conversation. The publication contributed the article to Space.com's Expert Voices: Op-Ed & Insights. Professional astronomers don’t make discoveries by ...
SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results